{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:54:57Z","timestamp":1773474897133,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":128,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014565","name":"Bausch Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.curtheres.2023.100705","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T02:03:25Z","timestamp":1683857005000},"page":"100705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Oxygen-Carrying Capacity of Perfluorohexyloctane, a Novel Eye Drop for Dry Eye Disease"],"prefix":"10.1016","volume":"98","author":[{"given":"Neal","family":"Stolowich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Vittitow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-591X","authenticated-orcid":false,"given":"Douglas","family":"Borchman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.curtheres.2023.100705_bib0001","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1089\/jop.2015.0048","article-title":"Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease\u2013A Prospective, Multicenter Noninterventional Study","volume":"31","author":"Steven","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.curtheres.2023.100705_bib0002","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1089\/jop.2017.0042","article-title":"Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease","volume":"33","author":"Steven","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.curtheres.2023.100705_bib0003","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/ICO.0000000000002622","article-title":"A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of PFHO for Treatment of Dry Eye Disease","volume":"40","author":"Tauber","year":"2021","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.curtheres.2023.100705_bib0004","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/jop.2019.0092","article-title":"Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial","volume":"36","author":"Schmidl","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000499158","article-title":"Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional Study","volume":"63","author":"Eberwein","year":"2020","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.curtheres.2023.100705_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2023.100704","article-title":"In vitro inhibition of evaporation with perfluorohexyloctane, an eye drop for dry eye disease","author":"Vittitow","year":"2023","journal-title":"Curr Therap Res"},{"key":"10.1016\/j.curtheres.2023.100705_bib0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0169-409X(01)00107-7","article-title":"Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research","volume":"47","author":"Krafft","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0008","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.colsurfb.2005.11.022","article-title":"Characterization of phospholipids+semifluorinated alkane vesicle system","volume":"47","author":"Sabin","year":"2006","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.curtheres.2023.100705_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(94)00153-P","article-title":"Hydrolysis of DMPC or DPPC by pancreatic phospholipase A2 is slowed down when (perfluoroalkyl) alkanes are incorporated into the liposomal membrane","volume":"1254","author":"Privitera","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.curtheres.2023.100705_bib0010","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3109\/08982109409018619","article-title":"Incorporation of a perfluoroalkane (RFRH) into the phopholipid bilalyer of dmpc liposomes results in greater encapsulation stability","volume":"4","author":"Trevino","year":"1994","journal-title":"Liposome Res"},{"key":"10.1016\/j.curtheres.2023.100705_bib0011","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0927-7757(94)02789-7","article-title":"Novel liposome systems based on the incorporation of (perfluoroalkyl)alkenes (FMHNE) into the bilayer of phospholipid liposomes","volume":"88","author":"Trevino","year":"1994","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.curtheres.2023.100705_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1388-1981(02)00116-6","article-title":"Incorporation of semi-fluorinated alkanes in the bilayer of small unilamellar vesicles of phosphatidylserine: impact on fusion kinetics","volume":"1581","author":"Ferro","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.curtheres.2023.100705_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110564","article-title":"Dynarowicz-Latka P. PFHO (F(6)H(8)) as a delivery agent for cyclosporine A in dry eye syndrome therapy - Langmuir monolayer study complemented with infrared nanospectroscopy","volume":"184","author":"Chachaj-Brekiesz","year":"2019","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.curtheres.2023.100705_bib0014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cis.2007.11.002","article-title":"Semifluorinated alkanes\u2014Primitive surfactants of fascinating properties","volume":"138","author":"Broniatowski","year":"2008","journal-title":"Adv Colloid Interf Sci"},{"issue":"3","key":"10.1016\/j.curtheres.2023.100705_bib0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of Meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"14","key":"10.1016\/j.curtheres.2023.100705_bib0016","doi-asserted-by":"crossref","first-page":"DES94","DOI":"10.1167\/iovs.17-23345","article-title":"Inflamed Obstructive Meibomian Gland Dysfunction Causes Ocular Surface Inflammation","volume":"59","author":"Suzuki","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.curtheres.2023.100705_bib0017","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.TR120000874","article-title":"Lipid conformational order and the etiology of cataract and dry eye","volume":"62","author":"Borchman","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.curtheres.2023.100705_bib0018","article-title":"PFHO for dry eye disease associated with meibomian gland dysfunction: Results of the randomized phase 3 GOBI study","author":"Tauber","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.curtheres.2023.100705_bib0019","first-page":"1531","article-title":"Efficacy of PFHO (perfluorohexyloctane) on signs and symptoms of dry eye disease associated with meibomian gland dysfunction: The MOJAVE Study","volume":"63","author":"Sheppard","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.curtheres.2023.100705_bib0020","unstructured":"Bausch & Lomb data on file"},{"issue":"7","key":"10.1016\/j.curtheres.2023.100705_bib0021","first-page":"1525","article-title":"Spectroscopic study of perfluorohexyloctane human meibum interactions","volume":"63","author":"Borchman","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100705_bib0022","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/10731199309117383","article-title":"The use of semifluorinated alkanes in blood-substitutes","volume":"21","author":"Meinert","year":"1993","journal-title":"Biomater Artif Cells Immobilization Biotechnol"},{"issue":"16","key":"10.1016\/j.curtheres.2023.100705_bib0023","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0142-9612(98)00071-4","article-title":"Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery","volume":"19","author":"Riess","year":"1998","journal-title":"Biomaterials"},{"key":"10.1016\/j.curtheres.2023.100705_bib0024","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1063\/1.437853","article-title":"Fluorocarbons as oxygen carriers. I An NMR study of oxygen solutions in hexafluorobenzene","volume":"70","author":"Delpuech","year":"1979","journal-title":"J. Chem Phys."},{"issue":"9","key":"10.1016\/j.curtheres.2023.100705_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/anie.197806213","article-title":"Perfluoro compounds as blood substitutes","volume":"17","author":"Riess","year":"1978","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"10.1016\/j.curtheres.2023.100705_bib0026","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11307-021-01648-3","article-title":"Prognostic Value of Fluorine-19 MRI Oximetry Monitoring in cancer","volume":"24","author":"Chapelin","year":"2022","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0027","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.2021200062","article-title":"Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with 19F MRI in a Murine Model","volume":"3","author":"Chapelin","year":"2021","journal-title":"Radiol Imaging Cancer"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100705_bib0028","doi-asserted-by":"crossref","first-page":"e59479","DOI":"10.1371\/journal.pone.0059479","article-title":"In vivo intracellular oxygen dynamics in murine brain glioma and immunotherapeutic response of cytotoxic T cells observed by fluorine-19 magnetic resonance imaging","volume":"8","author":"Zhong","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.curtheres.2023.100705_bib0029","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/ICO.0b013e31823f0930","article-title":"A quasi-2-dimensional model for respiration of the cornea with soft contact lens wear","volume":"31","author":"Takatori","year":"2012","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100705_bib0030","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/OPX.0b013e31819f9e70","article-title":"Modeling corneal metabolism and oxygen transport during contact lens wear","volume":"86","author":"Chhabra","year":"2009","journal-title":"Optom Vis Sci"},{"issue":"6","key":"10.1016\/j.curtheres.2023.100705_bib0031","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.preteyeres.2011.07.001","article-title":"Oxygen-deficient metabolism and corneal edema","volume":"30","author":"Leung","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0032","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00006324-196901000-00003","article-title":"Steady state distribution of oxygen and carbon dioxide in the in vivo cornea of an eye covered by a gas-permeable contact lens","volume":"46","author":"Fatt","year":"1969","journal-title":"Am J Optom Arch Am Acad Optom"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0033","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-4835(68)80032-6","article-title":"The steady-state distribution of oxygen and carbon dioxide in the in vivo cornea. I. The open eye in air and the closed eye","volume":"7","author":"Fatt","year":"1968","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.curtheres.2023.100705_bib0034","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0014-4835(68)80056-9","article-title":"Steady-state distribution of oxygen and carbon dioxide in the in vivo cornea. II. The open eye in nitrogen and the covered eye","volume":"7","author":"Fatt","year":"1968","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.curtheres.2023.100705_bib0035","first-page":"583","article-title":"The use of semifluorinated alkanes in blood-substitutes","volume":"21","author":"Meinert","year":"1993","journal-title":"Biomat Art Cells Immob Biotech"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100705_bib0036","first-page":"1704","article-title":"A method for estimating the solubility of gases in liquids","volume":"29","author":"Osburn","year":"1970","journal-title":"Fed Proc"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100705_bib0037","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1755-3768.1987.tb07040.x","article-title":"Critical oxygen requirements to avoid oedema of the central and peripheral cornea","volume":"65","author":"Brennan","year":"1987","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0038","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006324-198801000-00004","article-title":"Corneal oxygen availability during contact lens wear: a comparison of methodologies","volume":"65","author":"Brennan","year":"1988","journal-title":"Am J Optom Physiol Opt"},{"issue":"4","key":"10.1016\/j.curtheres.2023.100705_bib0039","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archopht.1970.00990040507021","article-title":"Critical oxygen tension at the corneal surface","volume":"84","author":"Polse","year":"1970","journal-title":"Arch Ophthalmol"},{"issue":"2980","key":"10.1016\/j.curtheres.2023.100705_bib0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.115.2980.140.a","article-title":"Importance of atmospheric oxygen for maintenance of the optical properties of the human cornea","volume":"115","author":"Smelser","year":"1952","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.curtheres.2023.100705_bib0041","first-page":"476","article-title":"The minimum precorneal oxygen tension to avoid corneal edema","volume":"25","author":"Holden","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.curtheres.2023.100705_bib0042","first-page":"644","article-title":"[Effects of anoxia on human cornea]","volume":"87","author":"Mizutani","year":"1983","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.curtheres.2023.100705_bib0043","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3109\/21691401.2015.1111228","article-title":"19F Oximetry with semifluorinated alkanes","volume":"44","author":"Kegel","year":"2016","journal-title":"Artif Cells Nanomed Biotech"},{"key":"10.1016\/j.curtheres.2023.100705_bib0044","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mrm.1910290304","article-title":"In vivo oxygen tension and temperature: Simultaneous determination using 19F NMR spectroscopy of perfluorocarbon","volume":"29","author":"Mason","year":"1993","journal-title":"MRM"},{"key":"10.1016\/j.curtheres.2023.100705_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/jmrb.1995.1023","volume":"106","author":"Shukula","year":"1995","journal-title":"J Mag Res B"},{"key":"10.1016\/j.curtheres.2023.100705_bib0046","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jmr.2014.01.014","article-title":"19F spin-lattice relaxation of perfluoropolyethers: dependence on temperature and magnetic field strength (7.0-14.1 T)","volume":"242","author":"Kadayakkara","year":"2014","journal-title":"J Mag Res"},{"issue":"12","key":"10.1016\/j.curtheres.2023.100705_bib0047","first-page":"448","article-title":"Hyperbaric oxygen therapy in the treatment of secondary keratoendotheliosis","volume":"24","author":"Recupero","year":"1992","journal-title":"Ann Ophthalmol"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0048","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/ICO.0b013e3181da58a4","article-title":"Use of adjuvant hyperbaric oxygen therapy to support limbal conjunctival graft in the management of recurrent pterygium","volume":"30","author":"Assaad","year":"2011","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.curtheres.2023.100705_bib0049","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0161-6420(95)30914-1","article-title":"Hyperbaric oxygen therapy for beta-radiation-induced scleral necrosis","volume":"102","author":"Green","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.curtheres.2023.100705_bib0050","first-page":"407","article-title":"Oxygen therapy and intraocular oxygenation","volume":"85","author":"Jampol","year":"1987","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.curtheres.2023.100705_bib0051","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archopht.1973.01000050092002","article-title":"Hyperbaric oxygen, retinal detachment, and sickle cell anemia","volume":"90","author":"Freilich","year":"1973","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.curtheres.2023.100705_bib0052","first-page":"86","article-title":"Hyperbaric oxygen therapy in two patients with non-arteritic anterior optic neuropathy who did not respond to prednisone","volume":"29","author":"Boji\u0107","year":"2002","journal-title":"Undersea Hyperb Med"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0053","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004954","article-title":"Hyperbaric oxygen therapy for multiple sclerosis","volume":"2004","author":"Bennett","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0054","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3928\/1542-8877-20020101-11","article-title":"Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis","volume":"33","author":"Bayer","year":"2002","journal-title":"Ophthalmic Surg Lasers"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100705_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3341\/kjo.2020.0076","article-title":"Efficacy of Hyperbaric Oxygen Therapy on Central Corneal Thickness, Intraocular Pressure, and Nerve Fiber Layer in Patients with Type 2 Diabetes: A Prospective Cohort Study","volume":"35","author":"Kald\u0131r\u0131m","year":"2021","journal-title":"Korean J Ophthalmol"},{"issue":"10","key":"10.1016\/j.curtheres.2023.100705_bib0056","first-page":"3061","article-title":"Impact of aging and hyperbaric oxygen in vivo on guinea pig lens lipids and nuclear light scatter","volume":"41","author":"Borchman","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X23000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X23000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:28:22Z","timestamp":1762122502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X23000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":56,"alternative-id":["S0011393X23000140"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2023.100705","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxygen-Carrying Capacity of Perfluorohexyloctane, a Novel Eye Drop for Dry Eye Disease","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2023.100705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100705"}}